Keywords: Litigation, Twombly, district courts, failure to state a claim, . Oct. 26, 2009); Anticancer Inc. v. Xenogen Corp., 248 F.R.D. 278, .

Jun 17, 2009 – Date Filed: 6/17/2009; Plaintiff: Anticancer, Inc.; Defendant: Fujifilm Medical Systems U.S.A., Inc et al; Cause: 28:2201 Injunction.

Nov 16, 2010 – (2 total) on 2004-07-06 (filed 2001-05-29) and assigned to AntiCancer, Inc.. . Currently involved in at least 1 patent litigation: v. .

Features of Olympus IV100 imaging system · Caliper and AntiCancer announce cross -licensing of intellectual property and settlement of litigation .

Sep 30, 2010 – BACKGROUND This action is a patent infringement lawsuit. On June 17, 2009, Plaintiff AntiCancer, Inc. ("AntiCancer") initiated this action .

May 10, 2005 – Free Online Library: Xenogen Files Answer and Counterclaims in Patent Infringement Litigation with AntiCancer Inc. by "PR Newswire"; .

His practice includes intellectual property litigation with a focus on patents. . potential anticancer drugs, agriculture and medical devices. . Watson Pharmaceuticals, Inc. and Watson Laboratories, Inc., Civil Action No. .

Jun 27, 2011 – Mauna Kea Technologies files declaratory judgement against Anticancer, Inc. in California Southern.

Van Camp Seafoods, Inc.: class action by fishermen alleging price fixing by . involving generic competition for anti-cancer drugs and the operation of the .

Other lawsuits settled. Honeywell International, Inc. v. . Lead counsel for Bayer in breach of contract lawsuit concerning anti-cancer compound. .

In Re Sourcefire, Inc. Securities Litigation (D. Md. 2009). . arising from defendant's breach of a contract for the development of an anti-cancer drug. .

Jun 21, 2011 – Xenogen Files Answer and Counterclaims in Patent Infringement Litigation with AntiCancer Inc. Xenogen Denies AntiCancer's Allegations and .

numerous serious side effects which have given rise to numerous lawsuits. . with a combination of Avastin and another anti-cancer drug, Xelox. . may file a lawsuit against Genentech Inc, Avastin's manufacturer, for their injuries. .

File Format: PDF/Adobe Acrobat - Quick View

Anticancer, Inc. Decision: Petition to Cancel Granted. Panel: Sams Seeherman Quinn*. Opposer's or Petitioner's Mark and Goods or Services: .

Peter D. Shapiro's practice focuses on patent litigation in the electrical and computer arts, . anti-cancer drugs, cholesterol lowering drugs and optical devices. . 2008: Nano-Proprietary, Inc. v. Canon Inc. and Canon U.S.A., Inc. .

Business Litigation · Disability Insurance. Novantrone (mitoxantrone) is an anti -cancer drug that was approved by the Food and Drug Administration (“FDA”) .

Joseph Coyne is a partner who handles complex litigation, including antitrust and . as Georgia Pacific, Northrop Grumman Corporation, American Bioscience and Honeywell Inc. . practices in conjunction with the anti-cancer drug Taxol. .

IP Litigation IP Counseling & Patents Life Sciences . Dell, Inc., et al. ( Eastern District of Texas) - Represented Dell in a jury trial involving multi- display systems for . composition against first-to-file generic; AntiCancer v. .

James Pistorino is a partner in the firm's Patent Litigation practice. . AntiCancer, Inc. v Cambridge Research Instrumentation, Inc., et al. .

Jan 12, 2007 – filed by Anticancer Inc t/w jury demand (patent letter prepared). . . 06-20- 2007, 23, NOTICE by Anticancer Inc Notice of Dismissal by .

Feb 26, 2008 – . of Intellectual Property and Settlement of Litigation . About AntiCancer, Inc. AntiCancer, founded in 1984 and based in San Diego, .

Los Angeles, CA – eForCity Corporation has sued Apple, Inc. seeking the Court's . . See e.g. Anticancer, Inc. v. Xenogen Corp., 248 F.R.D. 278 (S.D. Cal. .

Patent Litigation; Patent Prosecution; Patent Due Diligence Analysis . Apotex Inc. and Apotex Corp., Case No. 08-496 (GMS) (D. Del. 2010). . Apotex's ANDA to make a generic version of Sanofi-Aventis' anti-cancer product TAXOTERE®, .

Due to the expense involved in antitrust litigation, the Court rejected case . In Anticancer Inc. v. Xenogen Corp, the infringement pleadings stated: .

Results 1 - 50 of 73 – PROPERTY AND SETTLEMENT OF LITIGATION. . About AntiCancer, Inc. . 38k - 30 Jun 2011. 2. Targeted Proapoptotic Anticancer Drug .

SuperGen, Inc. Class Action class action complaint and other relevant . SuperGen is developing an anti-cancer portfolio of proprietary new drugs and .

Jun 14, 2011 – ImmunoGen, Inc. develops targeted anticancer therapeutics using the Company's . by the Private Securities Litigation Reform Act of 1995. .

. electronic book readers, anti-cancer polymers, and biomedical devices .

Nov 15, 2010 – AntiCancer, Inc. sues Berthold Technologies U.S.A., LLC et .

Jun 27, 2011 – Date Filed: 6/27/2011; Plaintiff: Mauna Kea Technologies .

AntiCancer, Inc. and Cambridge Research & Instrumentation. Settle Patent .

Jun 9, 2004 – Proprietary Nutritionals Inc. (PNI) and Abulkalam M. Shamsuddin, M.D., . will be presented at the Annual Anti-Cancer Conference in Corfu, .

May 10, 2005 – On March 3, 2006, Xenogen and AntiCancer, Inc. agreed to settle a lawsuit that AntiCancer originally filed against Xenogen in August 2001. .

Emily Evans focuses primarily on patent litigation and related counseling. . in the District of Delaware concerning nanoparticulate anti-cancer drugs. . Genentech, Inc. relating to the University's patent to DNA for human growth .

Mar 7, 2005 – Case Name: Anticancer Inc v. Xenogen Corporation, et al .

Mr. Lawton has successfully litigated cases against some of the largest law firms and . Genelux Corporation; Payrolling.com Corporation; AntiCancer, Inc.; .

Inogen, Inc.: Represented Inogen in two patent infringement lawsuit involving . AntiCancer, Inc. v. Caliper Life Sciences and Stanford University: .

Mar 11, 2011 – In connection with the settlement of our litigation with AntiCancer, Inc. in February 2008, we obtained license rights under AntiCancer's .

Sunrise Medical Hhg, Inc. Lawsuit for declaratory judgment, non-infringement and invalidity . . Anticancer Inc. Declaratory judgment of non-infringement. .

Dec 8, 2010 – Date Filed: 12/8/2010; Plaintiff: Anticancer, Inc .

File Format: PDF/Adobe Acrobat - Quick View

MIT engineers an anti-cancer smart bomb: Imagine a cancer drug that can burrow . Parker Jensen Lawsuit Raises New Questions: new lawsuit raises questions about . Insert Therapeutics, Inc. Chief Scientific Officer, Thomas Schluep, .

Feb 5, 2008 – Anticancer Inc v. Cambridge Research & Instrumentation, Inc. et al . to proceed in the `05 litigation free from Lawton's influence, .

Sep 30, 2010 – This action is a patent infringement lawsuit. On June 17, 2009, Plaintiff AntiCancer, Inc. ("AntiCancer") initiated this action by filing .

Nov 12, 2010 – Berthold Technologies. et. al. sued by AntiCancer, Inc. for .

Jan 14, 2009 – Date Filed: 1/14/2009; Plaintiff: AntiCancer Inc .

Oct 18, 2005 – . within the meaning of the Private Securities Litigation Reform Act of 1995. . Contact: AntiCancer, Inc. Sandy Wei 858-654-2555 .

May 8, 2011 – ImmunoGen, Inc. develops targeted anticancer therapeutics using the Company's . by the Private Securities Litigation Reform Act of 1995. .

1 History; 2 Products; 3 Anticancer claims; 4 Human pilot studies . a class action lawsuit was filed against FreeLife International, Inc. in the United .

Sitemap